
Sign up to save your podcasts
Or


It’s safe to say that IDNs are important customers for the overwhelming majority of medical device companies. Therefore, it’s probably rational to assume that medtech companies do a good job of tracking the changing IDN landscape, right? Wrong. Based on the 2014 ZS Associates Commercial Operations Benchmark Study, only 56% of medtech companies track IDN...[read more]
Related Stories
By Scott Nelson4.7
6868 ratings
It’s safe to say that IDNs are important customers for the overwhelming majority of medical device companies. Therefore, it’s probably rational to assume that medtech companies do a good job of tracking the changing IDN landscape, right? Wrong. Based on the 2014 ZS Associates Commercial Operations Benchmark Study, only 56% of medtech companies track IDN...[read more]
Related Stories

90,931 Listeners

153,546 Listeners

537 Listeners

9,538 Listeners

59 Listeners

49 Listeners

112,360 Listeners

56,503 Listeners

8,522 Listeners

21 Listeners

1,657 Listeners

16,868 Listeners

11,021 Listeners